Metallic nanoparticles as drug delivery system for the treatment of cancer

References

• Sarkar S, Horn G, Moulton K, et al. Cancer development, progression, and therapy: an epigenetic overview. Int J Mol Sci. 2013;14(10):21087–21113.
   PubMed Web of Science ®Google Scholar
• Fink DJ. Cancer overview. Cancer Res. 1979;39(7 Pt 2):2819–2821.
   PubMed Web of Science ®Google Scholar
• Falzone L, Salomone S, Libra M, et al. Evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol. 2018;9:1300.
   PubMed Web of Science ®Google Scholar
• Huang Z, Bao SD. Roles of main pro- and anti-angiogenic factors in tumor angiogenesis. World J Gastroenterol. 2004;10(4):463–470.
   PubMed Web of Science ®Google Scholar
• Stumpff J, Ghule PN, Shimamura A, et al. Spindle microtubule dysfunction and cancer predisposition. J Cell Physiol. 2014;229(12):1881–1883.
   PubMed Web of Science ®Google Scholar
• Hassanpour SH, Dehghani M. Review of cancer from perspective of molecular. J Cancer Res Pract. 2017;4(4):127–129.
   Google Scholar
• Blackadar CB. Historical review of the causes of cancer. World J Clin Oncol. 2016;7(1):54–86.
   PubMed Web of Science ®Google Scholar
• Cancer Statistics. - National Cancer Institute. 2020.
   Google Scholar
• Cancer statistics. - National Cancer Institute. 2019.
   Google Scholar
• WHO report on cancer. setting priorities, investing wisely and providing care for all. 2020.
   Google Scholar
• Arruebo M, Vilaboa N, Sáez-Gutierrez B, et al. Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 2011;3(3):3279–3330.
   PubMedGoogle Scholar
• Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52–79.
   PubMed Web of Science ®Google Scholar
• Balis FM. The Goal of Cancer Treatment. Oncologist. 1998;3(4):0.
   Google Scholar
• Cheng CT, Castro G, Liu CH, et al. Advanced nanotechnology: an arsenal to enhance immunotherapy in fighting cancer. Clin Chim Acta. 2019;492:12–19.
   PubMed Web of Science ®Google Scholar
• Da Silva CG, Rueda F, Löwik CW, et al. Combinatorial prospects of nano-targeted chemoimmunotherapy. Biomaterials. 2016;83:308–320.
   PubMed Web of Science ®Google Scholar
• Seebacher NA, Stacy AE, Porter GM, et al. Clinical development of targeted and immune based anti-cancer therapies. J. Exp. Clin. Cancer Res. BioMed Central Ltd. 2019;38:1–39.
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Akhter S, Jain GK, et al. Metallic nanoparticles: technology overview and drug delivery applications in oncology. Expert Opin Drug Deliv. 2010;7(8):927–942.
   PubMed Web of Science ®Google Scholar
• Yaqoob SB, Adnan R, Rameez Khan RM, et al. Gold, silver, and palladium nanoparticles: a chemical tool for biomedical applications. Front Chem. 2020;8:1–15.
   PubMed Web of Science ®Google Scholar
• Conde J, Doria G, Baptista P. Noble metal nanoparticles applications in cancer. J Drug Deliv. 2012;2012:1–12.
   Google Scholar
• Lin Z, Monteiro-Riviere NA, Riviere JE. Pharmacokinetics of metallic nanoparticles. Wiley Interdiscip Rev Nanomedicine Nanobiotechnology. 2015;7(2):189–217.
   PubMed Web of Science ®Google Scholar
• Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev. 2009;38(6):1759–1782.
   PubMed Web of Science ®Google Scholar
• Nowak M, Brown TD, Graham A, et al. Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow. Bioeng Transl Med. 2020;5(2):e10153.
   PubMed Web of Science ®Google Scholar
• Kang SH, Lee YK, Park IS, et al. Biomimetic gold nanoshell-loaded macrophage for photothermal biomedicine. Biomed Res Int. 2020;2020:5869235.
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28–51.
   PubMed Web of Science ®Google Scholar
• Nance E, Timbie K, Miller GW, et al. Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood - brain barrier using MRI-guided focused ultrasound. J Control Release. 2014;189:123–132.
   PubMed Web of Science ®Google Scholar
• Kennedy JE, Wu F, Ter Haar GR, et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 2004;42(1–9):931–935.
   PubMed Web of Science ®Google Scholar
• Jahanban-Esfahlan R, Massoumi B, Abbasian M, et al. Dual stimuli-responsive polymeric hollow nanocapsules as “smart” drug delivery system against cancer. Polym Technol Mater. 2020;59:1492–1504.
   Web of Science ®Google Scholar
• Jaimes-Aguirre L, Vianey Gibbens-Bandala B, Morales-Avila E, et al. Polymer-based drug delivery systems, development and pre-clinical status. Curr Pharm Des. 2016;22(19):2886–2903.
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Arami S. Potential applications of nanoshells in biomedical sciences. J. Drug Target. J Drug Target. 2014;22(3):175–190.
   PubMed Web of Science ®Google Scholar
• Din F Ud W, Aman A. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. 2017;12:7291–7309.
   PubMed Web of Science ®Google Scholar
• Khlebtsov N, Dykmana L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2011;40(3):1647–1671.
   PubMed Web of Science ®Google Scholar
• Johnston HJ, Hutchison G, Christensen FM, et al. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40(4):328–346.
   PubMed Web of Science ®Google Scholar
• Huang C, Hao Y, Nyagilo J, et al. Porous hollow gold nanoparticles for cancer SERS imaging. J Nano Res. 2010;10:137–148.
   Web of Science ®Google Scholar
• Mody VV, Siwale R, Singh A, et al. Introduction to metallic nanoparticles. J Pharm Bioallied Sci. 2010;2(4):282–289.
   PubMedGoogle Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16:71.
   PubMed Web of Science ®Google Scholar
• Evans ER, Bugga P, Asthana V, et al. Metallic nanoparticles for cancer immunotherapy. Mater Today. 2018;21(6):673–685.
   Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Davudian S, et al. The different mechanisms of cancer drug resistance: a brief review. Adv. Pharm. Bull. 2017;7(3):339–348.
   PubMed Web of Science ®Google Scholar
• Panigrahi AR, Pinder SE, Chan SY, et al. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome. J Pathol. 2004;204(1):93–100.
   PubMed Web of Science ®Google Scholar
• Huang L, Li X, Roberts J, et al. Differential role of P-glycoprotein and breast cancer resistance protein in drug distribution into brain, CSF and peripheral nerve tissues in rats. Xenobiotica. 2015;45(6):547–555.
   PubMed Web of Science ®Google Scholar
• Carabia J, Carpio C, Abrisqueta P, et al. Microenvironment regulates the expression of MIR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia. Sci Rep. 2017;7(1):1–10.
   PubMedGoogle Scholar
• Sathi GA, Tamamura R, Tsujigiwa H, et al. Analysis of immunoexpression of common cancer stem cell markers in ameloblastoma. Exp Ther Med. 2012;3(3):397–402.
   PubMed Web of Science ®Google Scholar
• Lal S, Link S, Halas NJ. Nano-optics from sensing to waveguiding. Nanosci Technol A Collect Rev from Nat Journals. 2009;1:213–220.
   Google Scholar
• Ahn S, Jung SY, Lee SJ. Gold nanoparticle contrast agents in advanced X-ray imaging technologies. Molecules. 2013;18(5):5858–5890.
   PubMed Web of Science ®Google Scholar
• Jain PK, Lee KS, El-Sayed IH, et al. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and BIomedicine. J Phys Chem B. 2006;110(14):7238–7248.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Han G, De M, et al. Gold nanoparticles in delivery applications☆. Adv Drug Deliv Rev. 2008;60(11):1307–1315.
   PubMed Web of Science ®Google Scholar
• Moorthi C, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci. 2011;14(1):67–77.
   PubMed Web of Science ®Google Scholar
• Caban S, Aytekin E, Sahin A, et al. Nanosystems for drug delivery. OA Drug Des Deliv. 2014;2:1–7.
   Google Scholar
• Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc. 2004;126(23):7206–7211.
   PubMed Web of Science ®Google Scholar
• Laurent S, Forge D, Port M, et al. Magnetic Iron Oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008;108(6):2064–2110.
   PubMed Web of Science ®Google Scholar
• Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther. 2006;13(4):283–287.
   PubMed Web of Science ®Google Scholar
• Ansari SM, Bhor RD, Pai KR, et al. Cobalt nanoparticles for biomedical applications: facile synthesis, physiochemical characterization, cytotoxicity behavior and biocompatibility. Appl Surf Sci. 2017;414:171–187.
   Web of Science ®Google Scholar
• Saha RN, Vasanthakumar S, Bende G, et al. Nanoparticulate drug delivery systems for cancer chemotherapy. Mol. Membr. Biol. 2010;27(7):215–231.
   PubMed Web of Science ®Google Scholar
• Fam SY, Chee CF, Yong CY, et al. Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials. 2020;10(4):787.
   Web of Science ®Google Scholar
• Shan GS, Liu XM, Chen HJ, et al. Investigation of laser heating effect of metallic nanoparticles on cancer treatment. IOP Conf Ser Mater Sci Eng. 2016;137:012013.
   Google Scholar
• Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019;12(7):908–931.
   Web of Science ®Google Scholar
• Cherukuri P, Glazer ES, Curley SA. Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev. 2010;62(3):339–345.
   PubMed Web of Science ®Google Scholar
• Sharma A, Goyal AK, Rath G. Recent advances in metal nanoparticles in cancer therapy. J Drug Target. 2018;26(8):617–632.
   PubMed Web of Science ®Google Scholar
• Vines JB, Yoon JH, Ryu NE, et al. Gold nanoparticles for photothermal cancer therapy. Front Chem. 2019;7:1–16.
   PubMed Web of Science ®Google Scholar
• Wu M, Huang S. Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (review). Mol Clin Oncol. 2017;7(5):738–746.
   PubMed Web of Science ®Google Scholar
• Drahansky M, Paridah M, Moradbak A, et al. We are IntechOpen, the world ’ s leading publisher of open access books built by scientists, for scientists TOP 1 %. Intech. 2016;i:13.
   Google Scholar
• Senturk Dalgic S. Size dependent properties of hollow gold nanoparticles: a theoretical investigation. Acta Phys Pol A. 2016;129(4):531–534.
   Web of Science ®Google Scholar
• Pankhurst QA, Connolly J, Jones SK, et al. Applications of magnetic nanoparticles in biomedicine [internet]. J Phys D Appl Phys. 2003;36(13):167–181.
   Web of Science ®Google Scholar
• Vallée F. Optical properties of metallic nanoparticles. Nanomater Nanochemistry. 2007; 197–227.
   Google Scholar
• Yang Z, Sun Z, Ren Y, et al. Advances in nanomaterials for use in photothermal and photodynamic therapeutics (review). Mol Med Rep. 2019;20(1):5–15.
   PubMed Web of Science ®Google Scholar
• Chen X-J, Sanchez-Gaytan BL, Qian Z, et al. Noble metal nanoparticles in DNA detection and delivery. Wiley Interdiscip Rev Nanomedicine Nanobiotechnology. 2012;4(3):273–290..
   PubMed Web of Science ®Google Scholar
• Agarwal A. Optical properties and application of metallic nanoparticles and their assembled. 2010.
   Google Scholar
• Venkatesh N. Metallic nanoparticle: a review. Biomed J Sci Tech Res. 2018;4:3765–3775.
   Google Scholar
• Schirrmacher V. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review). Int J Oncol. 2019;54(2):407–419.
   PubMed Web of Science ®Google Scholar
• Zugazagoitia J, Guedes C, Ponce S, et al. Current challenges in cancer treatment. Clin Ther. 2016;38(7):1551–1566.
   PubMed Web of Science ®Google Scholar
• Sun C, Veiseh O, Gunn J, et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small. 2008;4(3):372–379.
   PubMed Web of Science ®Google Scholar
• Shenoy D, Fu W, Li J, et al. Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery. Int J Nanomedicine. 2006;1(1):51–57.
   PubMed Web of Science ®Google Scholar
• Duskey JT, Rice KG. Nanoparticle ligand presentation for targeting solid tumors. AAPS PharmSciTech. 2014;15(5):1345–1354.
   PubMed Web of Science ®Google Scholar
• Mortezaee K, Najafi M, Samadian H, et al. Redox interactions and genotoxicity of metal-based nanoparticles: a comprehensive review. Chem Biol Interact. 2019;312:108814.
   PubMed Web of Science ®Google Scholar
• Dreaden EC, Austin LA, MacKey MA, et al. Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv. 2012;3(4):457–478.
   PubMedGoogle Scholar
• Sindhwani S, Syed AM, Ngai J, et al. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19(5):566–575.
   PubMed Web of Science ®Google Scholar
• Nichols JW, Yh B. EPR: evidence and fallacy [Internet]. J Control Release. 2014;190:451–464.
   PubMed Web of Science ®Google Scholar
• Khoshnevisan K, Daneshpour M, Barkhi M, et al. The promising potentials of capped gold nanoparticles for drug delivery systems. J Drug Target. 2018;26(7):525–532.
   PubMed Web of Science ®Google Scholar
• Massoumi B, Abbasian M, Jahanban-Esfahlan R, et al. PEGylated hollow pH-responsive polymeric nanocapsules for controlled drug delivery. Polym Int. 2020;69(5):519–527.
   Web of Science ®Google Scholar
• Zugazagoitia J, Guedes C, Ponce S, et al., Current challenges in cancer treatment. Clin Ther. 2016;38(7): 1551–1566.
   PubMed Web of Science ®Google Scholar
• Prieto M, Arenal R, Henrard L, et al., Morphological tunability of the plasmonic response: from hollow gold nanoparticles to gold nanorings. J Phys Chem C. 2014;118(49): 28804–28811.
   Web of Science ®Google Scholar
• Hoshyar N, Gray S, Han H, et al., The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 2016;11(6): 673–692.
   PubMed Web of Science ®Google Scholar
• Chen YC, Huang XC, Luo YL, et al., Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems. Sci Technol Adv Mater. 2013;14(4): 44407–44430.
   PubMed Web of Science ®Google Scholar
• Zhao NR, Wang YJ, Chen XF, et al. Preparation of bioactive nanoparticles in the system CaO-P2O5-SiO2 using microemulsions. Key Eng Mater. 2005;288–289:179–182.
   Google Scholar
• Tang H, Shen S, Guo J, et al. Gold nanorods@mSiO 2 with a smart polymer shell responsive to heat/near-infrared light for chemo-photothermal therapy. J Mater Chem. 2012;22(31):16095–16103.
   Web of Science ®Google Scholar
• Fang W, Yang J, Gong J, et al. Photo- and pH-triggered release of anticancer drugs from mesoporous silica-coated Pd@Ag nanoparticles. Adv Funct Mater. 2012;22(4):842–848.
   Web of Science ®Google Scholar
• Liao MY, Wu CH, Lai PS, et al., Surface state mediated NIR two-photon fluorescence of iron oxides for nonlinear optical microscopy. Adv Funct Mater. 2013;23(16): 2044–2051.
   Web of Science ®Google Scholar
• Lim EK, Kim T, Paik S, et al. Nanomaterials for theranostics: recent advances and future challenges. Chem. Rev. American Chemical Society. 2015;115:327–394.
   PubMed Web of Science ®Google Scholar
• Li Y, Lin TY, Luo Y, et al. A smart and versatile theranostic nanomedicine platform based on nanoporphyrin. Nat Commun. 2014;5(1):4712.
   PubMedGoogle Scholar
• Song X, Gong H, Liu T, et al. J-aggregates of organic dye molecules complexed with iron oxide nanoparticles for imaging-guided photothermal therapy under 915-nm light. Small. 2014;10(21):4362–4370.
   PubMed Web of Science ®Google Scholar
• Würthner F, Kaiser TE, Saha-Möller CR. J-aggregates: from serendipitous discovery to supramolecular engineering of functional dye materials. Angew Chem Int Educ. 2011;50(15):3376–3410.
   PubMed Web of Science ®Google Scholar
• Lewis Phillips GD, Li G, Dugger DL, et al. Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Res. 2008;68(22):9280–9290.
   PubMed Web of Science ®Google Scholar
• Song X, Zhang R, Liang C, et al. Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy. Biomaterials. 2015;57:84–92.
   PubMed Web of Science ®Google Scholar
• Liu TM, Conde J, Lipiński T, et al. Revisiting the classification of NIR-absorbing/emitting nanomaterials for in vivo bioapplications. NPG Asia Mater. 2016;8(8):1–25.
   Google Scholar
• Li F, Zhou X, Zhou H, et al. Reducing both Pgp overexpression and drug efflux with anti-cancer gold-paclitaxel nanoconjugates. PLoS One. 2016;11:1–16.
   Web of Science ®Google Scholar
• Han P, Martens W, Waclawik ER, et al. Metal nanoparticle photocatalysts: synthesis, characterization, and application. Part. Syst. Charact. 2018;35(6):1–16.
   Web of Science ®Google Scholar
• Albiter E, Valenzuela MA, Alfaro S, et al. Photocatalytic deposition of Ag nanoparticles on TiO2: metal precursor effect on the structural and photoactivity properties. J Saudi Chem Soc. 2015;19(5):563–573.
   Web of Science ®Google Scholar
• Á D-G, Diego-González L, Á G-F, et al. Synergistic effect of metal oxide nanoparticles on cell viability and activation of MAP kinases and NFκB. Int J Mol Sci. 2018;19:246.
   Web of Science ®Google Scholar
• Shittu KO, Bankole MT, Abdulkareem AS, et al. Application of gold nanoparticles for improved drug efficiency. Adv Nat Sci Nanosci Nanotechnol. 2017;8(3):035014.
   Google Scholar
• Golombek SK, May JN, Theek B, et al. Tumor targeting via EPR: strategies to enhance patient responses. Adv Drug Deliv Rev. 2018;130:17–38.
   PubMed Web of Science ®Google Scholar
• Veiseh O, Sun C, Fang C, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res. 2009;69(15):6200–6207.
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14(1):1–16.
   PubMedGoogle Scholar
• Bertrand N, Wu J, Xu X, et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25.
   PubMed Web of Science ®Google Scholar
• Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153(3):198–205.
   PubMed Web of Science ®Google Scholar
• Choi CHJ, Alabi CA, Webster P, et al. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc Natl Acad Sci U S A. 2010;107(3):1235–1240.
   PubMed Web of Science ®Google Scholar
• Paciotti GF, Tamarkin L. Biological and engineering considerations for developing tumor-targeting metallic nanoparticle drug-delivery systems. Nanoparticulate Drug Deliv Syst. CRC Press. 2019;.141–158.
   Google Scholar
• Jurašin DD, Ćurlin M, Capjak I, et al. Surface coating affects behavior of metallic nanoparticles in a biological environment. Beilstein J Nanotechnol. 2016;7:246–262.
   PubMed Web of Science ®Google Scholar
• Van HD, Berlin JM. Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles [Internet]. Ther Deliv. 2017;8(9):763–774.
   PubMed Web of Science ®Google Scholar
• Paunovic J, Vucevic D, Radosavljevic T, et al. Effects of metallic nanoparticles on physiological liver functions. Rev Adv Mater Sci. 2017;49:123–128.
   Web of Science ®Google Scholar
• Perrault SD, Walkey C, Jennings T, et al. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009;9(5):1909–1915.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao J, Tan T, et al. Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review. Int J Nanomedicine. 2020;15:2563–2582.
   PubMed Web of Science ®Google Scholar
• Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev. 2011;63(3):161–169.
   PubMed Web of Science ®Google Scholar
• Hirsjarvi S, Passirani C, Benoit J-P. Passive and active tumour targeting with nanocarriers. Curr Drug Discov Technol. 2011;8(3):188–196.
   PubMedGoogle Scholar
• Attia MF, Anton N, Wallyn J, et al. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol. 2019;71(8):1185–1198.
   PubMed Web of Science ®Google Scholar
• Bazak R, Houri M, Achy SEL, et al. Passive targeting of nanoparticles to cancer: a comprehensive review of the literature. Mol Clin Oncol. 2014;2(6):904–908. .
   PubMedGoogle Scholar
• Torchilin VP. Passive and active drug targeting: drug delivery to tumors as an example. Handb. Exp. Pharmacol. 2010;197:3–53.
   PubMedGoogle Scholar
• Wakaskar RR. International Journal of Drug Development Passive and Active Targeting in Tumor Microenvironment. Int. J. Drug Dev. Res. 2017;9:37–41.
   Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–951.
   PubMed Web of Science ®Google Scholar
• Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24(3):179–191.
   PubMed Web of Science ®Google Scholar
• Rosenblum D, Joshi N, Tao W, et al. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9(1):1–12.
   PubMedGoogle Scholar
• Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–760.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Tavares AJ, Dai Q, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1(5):16014.
   Web of Science ®Google Scholar
• Navya PN, Kaphle A, Srinivas SP, et al. Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Converg. 2019;6:23.
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20–37.
   PubMed Web of Science ®Google Scholar
• Gullotti E, Yeo Y. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol Pharm. 2009;6(4):1041–1051.
   PubMed Web of Science ®Google Scholar
• Sultana S, Khan MR, Kumar M, et al. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. J Drug Target. 2013;21(2):107–125.
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135–146.
   PubMed Web of Science ®Google Scholar
• Huynh NT, Roger E, Lautram N, et al. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. Nanomedicine. 2010;5(9):1415–1433.
   PubMed Web of Science ®Google Scholar
• Li Y, Kröger M, Liu WK. Endocytosis of PEGylated nanoparticles accompanied by structural and free energy changes of the grafted polyethylene glycol. Biomaterials. 2014;35(30):8467–8478.
   PubMed Web of Science ®Google Scholar
• Choi JS, Park JS. Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting. Drug Des Devel Ther. 2017;11:17–26.
   PubMed Web of Science ®Google Scholar
• Azizi M, Ghourchian H, Yazdian F, et al. Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line. Sci Rep. 2017;7(1):5178.
   PubMedGoogle Scholar
• An FF, Zhang XH. Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery. Theranostics. 2017;7(15):3667–3689.
   PubMed Web of Science ®Google Scholar
• Hyun H, Park J, Willis K, et al. Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors. Biomaterials. 2018;180:206–224.
   PubMed Web of Science ®Google Scholar
• Guo X, Shi C, Yang G, et al. Dual-responsive polymer micelles for target-cell-specific anticancer drug delivery. Chem Mater. 2014;26(15):4405–4418.
   Web of Science ®Google Scholar
• Dellian M, Yuan F, Trubetskoy VS, et al. Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer. 2000;82(9):1513–1518.
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa T, Maeda H. Factors and mechanism of “EPR” effect and the enhanced antitumor effects of macromolecular drugs including SMANCS. Adv Exp Med Biol. 2003;519:29–49.
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release. 2001;74(1–3):47–61.
   PubMed Web of Science ®Google Scholar
• Li Y, Kröger M, Liu WK. Shape effect in cellular uptake of PEGylated nanoparticles: comparison between sphere, rod, cube and disk. Nanoscale. 2015;7(40):16631–16646.
   PubMed Web of Science ®Google Scholar
• Enrique MA, Mariana OR, Mirshojaei SF, et al. Multifunctional radiolabeled nanoparticles: strategies and novel classification of radiopharmaceuticals for cancer treatment. J Drug Target. 2015;23(3):191–201.
   PubMed Web of Science ®Google Scholar
• Mirshojaei SF, Ahmadi A, Morales-Avila E, et al. Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer. J Drug Target. 2016;24(2):91–101.
   PubMed Web of Science ®Google Scholar
• Radović M, Calatayud MP, Goya GF, et al., Preparation and in vivo evaluation of multifunctional 90 Y-labeled magnetic nanoparticles designed for cancer therapy. J Biomed Mater Res - Part A. 2015;103(1): 126–134.
   PubMed Web of Science ®Google Scholar
• Lee W-H, Loo C-Y, Leong C-R, et al. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer. Expert Opin Drug Deliv. 2017;14(8):937–957.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Meng F, Deng C, et al. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Biomacromolecules. 2014;15(6):1955–1969.
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Satapathy B, Mondal L, et al. Potentials and challenges of active targeting at the tumor cells by engineered polymeric nanoparticles. Curr Pharm Biotechnol. 2014;14(15):1250–1263.
   Web of Science ®Google Scholar
• Bayram B, Ozgur A, Tutar L, et al. Tumor targeting of polymeric nanoparticles conjugated with peptides, saccharides, and small molecules for anticancer drugs. Curr Pharm Des. 2017;23(35):5349–5357.
   PubMed Web of Science ®Google Scholar
• Yoo J, Park C, Yi G, et al. Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers (Basel). 2019;11(5):640.
   PubMed Web of Science ®Google Scholar
• Bazak R, Houri M, El ACHYS, et al. Passive targeting of nanoparticles to cancer: a comprehensive review of the literature. Mol Clin Oncol. 2014;2(6):904–908.
   PubMedGoogle Scholar
• Elizabeth D, Peter B, Amy G, et al. Beyond the EPR effect: targeting of nanoparticles to pediatric brain tumors. Front Bioeng Biotechnol. 2016;4.
   PubMedGoogle Scholar
• Gonda A, Zhao N, Shah JV, et al. Engineering tumor-targeting nanoparticles as vehicles for precision nanomedicine. Med One. 2019;4:e190021.
   PubMedGoogle Scholar
• Lynch CC, Hikosaka A, Acuff HB, et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell. 2005;7(5):485–496.
   PubMed Web of Science ®Google Scholar
• Huynh NT, Roger E, Lautram N, et al. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. Nanomedicine. 2010;5(9):1415–1433.
   PubMed Web of Science ®Google Scholar
• Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev. 2008;60(15):1615–1626.
   PubMed Web of Science ®Google Scholar
• Bogart LK, Pourroy G, Murphy CJ, et al. Nanoparticles for imaging, sensing, and therapeutic intervention. ACS Nano. 2014;8(4):3107–3122.
   PubMed Web of Science ®Google Scholar
• Subhan MA, Torchilin VP. Efficient nanocarriers of siRNA therapeutics for cancer treatment. Transl Res. 2019;214:62–91.
   PubMed Web of Science ®Google Scholar
• Smithies O, Lawrence M, Testen A, et al. Stable oligomeric clusters of gold nanoparticles: preparation, size distribution, derivatization, and physical and biological properties. Langmuir. 2014;30(44):13394–13404.
   PubMed Web of Science ®Google Scholar
• Lok CN, Zou T, Zhang JJ, et al. Controlled-release systems for metal-based nanomedicine: encapsulated/self-assembled nanoparticles of anticancer gold(III)/platinum(II) complexes and antimicrobial silver nanoparticles. Adv Mater. 2014;26(31):5550–5557.
   PubMed Web of Science ®Google Scholar
• Josan JS, Handl HL, Sankaranarayanan R, et al. Cell-specific targeting by heterobivalent ligands. Bioconjug Chem. 2011;22(7):1270–1278.
   PubMed Web of Science ®Google Scholar
• Munoz EM, Correa J, Riguera R, et al. Real-time evaluation of binding mechanisms in multivalent interactions: a surface plasmon resonance kinetic approach. J Am Chem Soc. 2013;135(16):5966–5969.
   PubMed Web of Science ®Google Scholar
• Chen J, Almo SC, Wu Y. General principles of binding between cell surface receptors and multi-specific ligands: a computational study. Morozov A V, editor. PLOS Comput Biol. 2017;13(10):e1005805.
   PubMed Web of Science ®Google Scholar
• Paszko E, Senge MO. Immunoliposomes. Curr Med Chem. 2012;19(31):5239–5277.
   PubMed Web of Science ®Google Scholar
• Toporkiewicz M, Meer J, Matusewicz L, et al. Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges. Int J Nanomedicine. 2015;10:1399–1414.
   PubMed Web of Science ®Google Scholar
• Friedman A, Claypool S, Liu R. The smart targeting of nanoparticles. Curr Pharm Des. 2013;19(35):6315–6329.
   PubMed Web of Science ®Google Scholar
• Cecioni S, Faure S, Darbost U, et al. Selectivity among two lectins: probing the effect of topology, multivalency and flexibility of “clicked” multivalent glycoclusters. Chem - A Eur J. 2011;17(7):2146–2159.
   PubMed Web of Science ®Google Scholar
• Lundquist JJ, Toone EJ. The cluster glycoside effect. Chem Rev. 2002;102(2):555–578.
   PubMed Web of Science ®Google Scholar
• Kane RS. Thermodynamics of multivalent interactions: influence of the linker. Langmuir. 2010;26(11):8636–8640.
   PubMed Web of Science ®Google Scholar
• Mammen M, Choi SK, Whitesides GM. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Educ. 1998;37(20):2754–2794.
   PubMed Web of Science ®Google Scholar
• Ashley CE, Carnes EC, Phillips GK, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater. 2011;10(5):389–397.
   PubMed Web of Science ®Google Scholar
• Zarbock A, Ley K, McEver RP, et al. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.Blood. 2011;118(26):6743–6751.
   PubMed Web of Science ®Google Scholar
• Wu AM, Yazaki PJ, Tsai SW, et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A. 2000;97(15):8495–8500.
   PubMed Web of Science ®Google Scholar
• Pirollo KF, Chang EH. Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol. 2008;26(10):552–558.
   PubMed Web of Science ®Google Scholar
• Bartlett DW, Su H, Hildebrandt IJ, et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A. 2007;104(39):15549–15554.
   PubMed Web of Science ®Google Scholar
• Rangel R, Guzman-Rojas L, Le Roux LG, et al. Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells. Nat Commun. 2012;3(1):1–10.
   Google Scholar
• Attia MF, Anton N, Wallyn J, et al. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol. 2019;71(8):1185–1198.
   PubMed Web of Science ®Google Scholar
• Clemons TD, Singh R, Sorolla A, et al. Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy. Langmuir. 2018;34(50):15343–15349.
   PubMed Web of Science ®Google Scholar
• Bazak R, Houri M, El Achy S, et al. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol. 2015;141(5):769–784.
   PubMed Web of Science ®Google Scholar
• Lin J, Miao L, Zhong G, et al. Understanding the synergistic effect of physicochemical properties of nanoparticles and their cellular entry pathways. Commun Biol. 2020;3(1):205.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shipton MK, Ryan J, et al. Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal Chem. 2007;79(6):2221–2229.
   PubMed Web of Science ®Google Scholar
• Kester M, Heakal Y, Fox T, et al. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett. 2008;8(12):4116–4121.
   PubMed Web of Science ®Google Scholar
• Jiang W, Kim BYS, Rutka JT, et al. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3(3):145–150.
   PubMed Web of Science ®Google Scholar
• Sarangthem V, Kim Y, Singh TD, et al., Multivalent targeting based delivery of therapeutic peptide using AP1-ELP carrier for effective cancer therapy. Theranostics. 2016;6(12): 2235–2249.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang M, Gan H, et al. A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nat Commun. 2018;9(1):2949.
   PubMedGoogle Scholar
• Cohen G, Burks SR, Frank JA. Chlorotoxin—A multimodal imaging platform for targeting glioma tumors. Toxins (Basel). 2018;10(12):1–12.
   Web of Science ®Google Scholar
• Dardevet L, Rani D, El Aziz TA, et al. Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion. Toxins (Basel). 2015;7(4):1079–1101.
   PubMed Web of Science ®Google Scholar
• Sun C, Veiseh O, Gunn J, et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small. 2008;4(3):372–379.
   PubMed Web of Science ®Google Scholar
• Banu H, Sethi DK, Edgar A, et al. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines. J Photochem Photobiol B Biol. 2015;149:116–128.
   PubMed Web of Science ®Google Scholar
• Zeinizade E, Tabei M, Shakeri-Zadeh A, et al. Selective apoptosis induction in cancer cells using folate-conjugated gold nanoparticles and controlling the laser irradiation conditions. Artif Cells Nanomed Biotechnol. 2018;46(sup1):1026–1038.
   PubMed Web of Science ®Google Scholar
• Pérez-Hernández M, Del Pino P, Mitchell SG, et al. Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms. ACS Nano. 2015;9(1):52–61.
   PubMed Web of Science ®Google Scholar
• Montazerabadi A, Beik J, Irajirad R, et al. Folate-modified and curcumin-loaded dendritic magnetite nanocarriers for the targeted thermo-chemotherapy of cancer cells. Artif Cells Nanomed Biotechnol. 2019;47(1):330–340.
   PubMed Web of Science ®Google Scholar
• Movahedi MM, Mehdizadeh A, Koosha F, et al. Investigating the photo-thermo-radiosensitization effects of folate-conjugated gold nanorods on KB nasopharyngeal carcinoma cells. Photodiagnosis Photodyn Ther. 2018;24:324–331.
   PubMed Web of Science ®Google Scholar
• Khademi S, Sarkar S, Shakeri-Zadeh A, et al. Dual-energy CT imaging of nasopharyngeal cancer cells using multifunctional gold nanoparticles. IET Nanobiotechnol. 2019;13(9):957–961.
   PubMed Web of Science ®Google Scholar
• Khademi S, Sarkar S, Shakeri-Zadeh A, et al. Targeted gold nanoparticles enable molecular CT imaging of head and neck cancer: an in vivo study. Int J Biochem Cell Biol. 2019;114:105554.
   PubMed Web of Science ®Google Scholar
• Tiefenauer LX, Kühne G, Andres RY. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjug Chem. 1993;4(5):347–352.
   PubMed Web of Science ®Google Scholar
• Bulte JWM, Hoekstra Y, Kamman RL, et al. Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles. Magn Reson Med. 1992;25(1):148–157.
   PubMed Web of Science ®Google Scholar
• Kirpotin D, Park JW, Hong K, et al. Sterically stabilized Anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro†. Biochemistry. 1997;36(1):66–75.
   PubMed Web of Science ®Google Scholar
• Huh YM, Jun YW, Song HT, et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc. 2005;127(35):12387–12391.
   PubMed Web of Science ®Google Scholar
• Mrsny R. Active targeting strategies in cancer with a focus on potential nanotechnology applications. Nanotechnol Cancer Ther. 2006; .19–42.
   Google Scholar
• Ratan ZA, Haidere MF, Nurunnabi M, et al. Green chemistry synthesis of silver nanoparticles and their potential anticancer effects. Cancers (Basel). 2020;12(4):855.
   PubMed Web of Science ®Google Scholar
• Wong OA, Hansen RJ, Ni TW, et al. Structure-activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine model. Nanoscale. 2013;5(21):10525–10533.
   PubMed Web of Science ®Google Scholar
• Feliu N, Docter D, Heine M, et al. In vivo degeneration and the fate of inorganic nanoparticles. Chem Soc Rev. 2016;45(9):2440–2457.
   PubMed Web of Science ®Google Scholar
• Peng C, Zheng L, Chen Q, et al. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials. 2012;33(4):1107–1119.
   PubMed Web of Science ®Google Scholar
• Terentyuk GS, Maslyakova GN, Suleymanova LV, et al. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. J Biophotonics. 2009;2(5):292–302.
   PubMed Web of Science ®Google Scholar
• Kattumuri V, Katti K, Bhaskaran S, et al. Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies. Small. 2007;3(2):333–341.
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim P, Yoon J, et al., Serum kinetics, distribution and excretion of silver in rabbits following 28 days after a single intravenous injection of silver nanoparticles. Nanotoxicology. 2013;7(6): 1120–1130.
   PubMed Web of Science ®Google Scholar
• Balfourier A, Luciani N, Wang G, et al., Unexpected intracellular biodegradation and recrystallization of gold nanoparticles. Proc Natl Acad Sci U S A. 2020;117(1): 103–113.
   PubMed Web of Science ®Google Scholar
• Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2011;40(3):1647–1671.
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2009;236(1):16–24.
   PubMed Web of Science ®Google Scholar
• Konoeda H, Takizawa H, Gower A, et al. Pharmacokinetics, tissue distribution and safety of gold nanoparticle/PKC Delta inhibitor peptide hybrid in rats. Nanotoxicology. 2020;14(3):341–354.
   PubMed Web of Science ®Google Scholar
• Guo M, Que C, Wang C, et al. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. Biomaterials. 2011;32(1):185–194.
   PubMed Web of Science ®Google Scholar
• Fu C, Liu T, Li L, et al. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials. 2013;34(10):2565–2575.
   PubMed Web of Science ®Google Scholar
• Jenkins JT, Halaney DL, Sokolov KV, et al. Excretion and toxicity of gold-iron nanoparticles. Nanomed Nanotechnol Biol Med. 2013;9(3):356–365.
   PubMed Web of Science ®Google Scholar
• Hauser M, Nowack B. Meta-analysis of pharmacokinetic studies of nanobiomaterials for the prediction of excretion depending on particle characteristics. Front Bioeng Biotechnol. 2019;7:405.
   PubMed Web of Science ®Google Scholar
• Lopez-Chaves C, Soto-Alvaredo J, Montes-Bayon M, et al. Gold nanoparticles: distribution, bioaccumulation and toxicity. vitro and in vivo studies. Nanomedicine Nanotechnology, Biol Med. 2018;14(1):1–12.
   PubMed Web of Science ®Google Scholar
• Sadauskas E, Danscher G, Stoltenberg M, et al. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine. 2009;5(2):162–169.
   PubMed Web of Science ®Google Scholar
• Carlson C, Hussein SM, Schrand AM, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008;112(43):13608–13619.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim JS, Cho HS, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol. 2008;20(6):575–583.
   PubMed Web of Science ®Google Scholar
• Park K, Park EJ, Chun IK, et al. Bioavailability and Toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res. 2011;34(1):153–158.
   PubMed Web of Science ®Google Scholar
• Lankveld DPK, Oomen AG, Krystek P, et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials. 2010;31(32):8350–8361.
   PubMed Web of Science ®Google Scholar
• Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A, et al. Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol. 2012;32:920–928.
   PubMed Web of Science ®Google Scholar
• Lee JH, Sung JH, Ryu HR, et al. Tissue distribution of gold and silver after subacute intravenous injection of co-administered gold and silver nanoparticles of similar sizes. Arch Toxicol. 2018;92(4):1393–1405.
   PubMed Web of Science ®Google Scholar
• Loeschner K, Hadrup N, Qvortrup K, et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol. 2011;8.18. DOI: 10.1186/1743-8977-8-18.
   PubMed Web of Science ®Google Scholar
• Xue Y, Zhang S, Huang Y, et al. Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. J Appl Toxicol. 2012;32(11):890–899.
   PubMed Web of Science ®Google Scholar
• Mao BH, Chen ZY, Wang YJ, et al. Silver nanoparticles have lethal and sublethal adverse effects on development and longevity by inducing ROS-mediated stress responses. Sci Rep. 2018;8(1):1–16.
   PubMedGoogle Scholar
• Hadrup N, Lam HR. Oral toxicity of silver ions, silver nanoparticles and colloidal silver–a review. Regul Toxicol Pharmacol. 2014;68(1):1–7.
   PubMed Web of Science ®Google Scholar
• Pem B, Pongrac IM, Ulm L, et al. Toxicity and safety study of silver and gold nanoparticles functionalized with cysteine and glutathione. Beilstein J Nanotechnol. 2019;10:1802–1817.
   PubMed Web of Science ®Google Scholar
• Recordati C, De Maglie M, Bianchessi S, et al. Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects. Part Fibre Toxicol. 2016;13(1):12.
   PubMedGoogle Scholar
• Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A, et al. Time-dependent biodistribution and excretion of silver nanoparticles in male wistar rats. J Appl Toxicol. 2012;32(11):920–928.
   PubMed Web of Science ®Google Scholar
• Spencer AP, Torrado M, Custódio B, et al. Breaking barriers: bioinspired strategies for targeted neuronal delivery to the central nervous system. Pharmaceutics. 2020;12(2):192.
   Web of Science ®Google Scholar
• Van Der Zande M, Vandebriel RJ, Van Doren E, et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano. 2012;6(8):7427–7442.
   PubMed Web of Science ®Google Scholar
• Akter M, Sikder MT, Rahman MM, et al. A systematic review on silver nanoparticles-induced cytotoxicity: physicochemical properties and perspectives. J Adv Res. 2018;9:1–16.
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces. 2008;66(2):274–280.
   PubMed Web of Science ®Google Scholar
• Gerber A, Bundschuh M, Klingelhofer D, et al. Gold nanoparticles: recent aspects for human toxicology. J Occup Med Toxicol. 2013;8(1):32.
   PubMedGoogle Scholar
• Bailly AL, Correard F, Popov A, et al. In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles. Sci Rep. 2019;9(1):1–12.
   PubMedGoogle Scholar
• Kong B, Seog JH, Graham LM, et al. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine. 2011;6(5):929–941.
   PubMed Web of Science ®Google Scholar
• Zhang X-D, Wu D, Shen X, et al. In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials. 2012;33(18):4628–4638.
   PubMed Web of Science ®Google Scholar
• Raftis JB, Miller MR. Nanoparticle translocation and multi-organ toxicity: a particularly small problem. Nano Today. 2019;26:8–12.
   PubMed Web of Science ®Google Scholar
• Sabella S, Galeone A, Vecchio G. AuNPs are toxic in vitro and in vivo: a review. J Nanosci Lett. 2011;1:145–165.
   Google Scholar
• Yah CS. The toxicity of gold nanoparticles in relation to their physiochemical properties. Biomed Res. 2013;24:400–413.
   Web of Science ®Google Scholar
• Semmler-Behnke M, Kreyling WG, Lipka J, et al. Biodistribution of 1.4- and 18-nm gold particles in rats. Small. 2008;4(12):2108–2111.
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Sano A, et al. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces. 2008;65(1):1–10.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29(12):1912–1919.
   PubMed Web of Science ®Google Scholar
• Ferdous Z, Nemmar A. Health impact of silver nanoparticles: a review of the biodistribution and toxicity following various routes of exposure. Int J Mol Sci. 2020;21(7):2375.
   PubMed Web of Science ®Google Scholar
• Mortezaee K, Najafi M, Samadian H, et al. Redox interactions and genotoxicity of metal-based nanoparticles: a comprehensive review. Chem Biol Interact. 2019;312:108814.
   PubMed Web of Science ®Google Scholar
• Azarnezhad A, Samadian H, Jaymand M, et al. Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers? [Internet]. Crit Rev Toxicol. 2020;50(2):148–176.
   PubMed Web of Science ®Google Scholar
• Barabadi H, Najafi M, Samadian H, et al. A systematic review of the genotoxicity and antigenotoxicity of biologically synthesized metallic nanomaterials: are green nanoparticles safe enough for clinical marketing? Med. 2019;55:439.
   Google Scholar
• Xia Q, Li H, Liu Y, et al. The effect of particle size on the genotoxicity of gold nanoparticles. J Biomed Mater Res - Part A. 2017;105(3):710–719.
   PubMed Web of Science ®Google Scholar
• Plotnikov E, Zhuravkov S, Gapeyev A, et al. Investigation of genotoxicity of gold nanoparticles prepared by the electric spark dispersion method. Adv Mater Res. 2014;1040:65–69.
   Google Scholar
• Nie S. Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Sci (80-). 1997;275(5303):1102–1106.
   PubMed Web of Science ®Google Scholar
• Neddersen J, Chumanov G, Cotton TM. Laser ablation of metals: a new method for preparing SERS active colloids. Appl Spectrosc. 1993;47(12):1959–1964.
   Web of Science ®Google Scholar
• Cole LE, Ross RD, Tilley JM, et al. Gold nanoparticles as contrast agents in X-ray imaging and computed tomography. Nanomedicine. 2015;10(2):321–341.
   PubMed Web of Science ®Google Scholar
• Cai W. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl. 2008;1:17–32.
   PubMedGoogle Scholar
• Pissuwan D, Niidome T, Cortie MB. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release. 2011;149(1):65–71.
   PubMed Web of Science ®Google Scholar
• Norouzi M. Gold nanoparticles in glioma theranostics. Pharmacol Res. 2020;156:104753. Academic Press.
   PubMed Web of Science ®Google Scholar
• Grafals-Ruiz N, Rios-Vicil CI, Lozada-Delgado EL, et al. Brain targeted gold liposomes improve rnai delivery for glioblastoma. Int J Nanomedicine. 2020;15:2809–2828.
   PubMed Web of Science ®Google Scholar
• Joshi PP, Yoon SJ, Hardin WG, et al. Conjugation of antibodies to gold nanorods through fc portion: synthesis and molecular specific imaging. Bioconjug Chem. 2013;24(6):878–888.
   PubMed Web of Science ®Google Scholar
• Kim S, Chen Y-S, Luke GP, et al. In vivo three-dimensional spectroscopic photoacoustic imaging for monitoring nanoparticle delivery. Biomed Opt Express. 2011;2(9):2540.
   PubMed Web of Science ®Google Scholar
• Niidome T, Yamagata M, Okamoto Y, et al. PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release. 2006;114(3):343–347.
   PubMed Web of Science ®Google Scholar
• Sershen SR, Westcott SL, Halas NJ, et al. Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery. J Biomed Mater Res. 2000;51(3):293–298.
   PubMed Web of Science ®Google Scholar
• Lasic DD, Needham D. The “Stealth” liposome: a prototypical biomaterial. Chem Rev. 1995;95(8):2601–2628.
   Web of Science ®Google Scholar
• Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today. 2002;7(10):569–579.
   PubMed Web of Science ®Google Scholar
• Brust M, Walker M, Bethell D, et al. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid–liquid system. J Chem Soc Chem Commun. 1994;0(7):801–802.
   Google Scholar
• Skrabalak SE, Chen J, Sun Y, et al. Gold nanocages: synthesis, properties, and applications. Acc Chem Res. 2008;41(12):1587–1595. .
   PubMed Web of Science ®Google Scholar
• Fang C, Wang K, Stephen ZR, et al. Temozolomide nanoparticles for targeted glioblastoma therapy. ACS Appl Mater Interfaces. 2015;7(12):6674–6682. .
   PubMed Web of Science ®Google Scholar
• Brown SD, Nativo P, Smith JA, et al. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc. 2010;132(13):4678–4684. .
   PubMed Web of Science ®Google Scholar
• Farooq MU, Novosad V, Rozhkova EA, et al. Gold nanoparticles-enabled efficient dual delivery of anticancer therapeutics to hela cells. Sci Rep. 2018;8(1):1–12. .
   PubMedGoogle Scholar
• Kwon YM, Je JY, Cha SH, et al. Synergistic combination of chemo‑phototherapy based on temozolomide/ICG‑loaded iron oxide nanoparticles for brain cancer treatment. Oncol Rep. 2019;42(5):1709–1724. .
   PubMed Web of Science ®Google Scholar
• Irani M, Mir Mohamad Sadeghi G, Haririan I. A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide. Int J Biol Macromol. 2017;97:744–751.
   PubMed Web of Science ®Google Scholar
• Gao Y, Torrente-Murciano L. Mechanistic insights of the reduction of gold salts in the turkevich protocol. Nanoscale. 2020;12(4):2740–2751.
   PubMed Web of Science ®Google Scholar
• Amado FR. Masterplan cultural para o bahrain. 2011;7:753–763.
   Google Scholar
• Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat Phys Sci. 1973;241(105):20–22.
   Web of Science ®Google Scholar
• Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold [internet]. Discuss Faraday Soc. 1951;11:55–75.
   Google Scholar
• Cunnane VJ, Schiffrin DJ, Beltran C, et al. The role of phase transfer catalysts in two phase redox reactions. J Electroanal Chem. 1988;247(1–2):203–214.
   Web of Science ®Google Scholar
• Hostetler MJ, Templeton AC, Murray RW. Dynamics of place-exchange reactions on monolayer-protected gold cluster molecules. Langmuir. 1999;15(11):3782–3789.
   Web of Science ®Google Scholar
• Laibinis PE, Nuzzo RG, Whitesides GM. Structure of monolayers formed by coadsorption of two n-alkanethiols of different chain lengths on gold and its relation to wetting. J Phys Chem. 1992;96(12):5097–5105.
   Web of Science ®Google Scholar
• Massoumi B, Farnudiyan‐Habibi A, Derakhshankhah H, et al. A novel multi-stimuli-responsive theranostic nanomedicine based on Fe3O4@Au nanoparticles against cancer. Drug Dev Ind Pharm. 2020;46(11):1832.
   PubMedGoogle Scholar
• Samadian H, Mohammad-Rezaei R, Jahanban-Esfahlan R, et al. A de novo theranostic nanomedicine composed of PEGylated graphene oxide and gold nanoparticles for cancer therapy. J Mater Res. 2020;35(4):430–441.
   Web of Science ®Google Scholar
• Moloudi K, Samadian H, Jaymand M, et al. Iron oxide/gold nanoparticles-decorated reduced graphene oxide nanohybrid as the thermo-radiotherapy agent. IET Nanobiotechnol. 2020;14(5):428–432.
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK, El-Sayed IH, et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008;23(3):217–228.
   PubMed Web of Science ®Google Scholar
• Pedrosa P, Corvo ML, Ferreira-Silva M, et al. Targeting cancer resistance via multifunctional gold nanoparticles. Int J Mol Sci. 2019;20(21):5510.
   Web of Science ®Google Scholar
• Pedrosa P, Mendes R, Cabral R, et al. Combination of chemotherapy and Au-nanoparticle photothermy in the visible light to tackle doxorubicin resistance in cancer cells. Sci Rep. 2018;8(1):1–8.
   PubMedGoogle Scholar
• Roma-Rodrigues C, Pombo I, Fernandes AR, et al. Hyperthermia induced by gold nanoparticles and visible light photothermy combined with Chemotherapy to Tackle Doxorubicin sensitive and resistant colorectal tumor 3D spheroids. Int J Mol Sci. 2020;21(21):8017.
   Web of Science ®Google Scholar
• Klar T, Perner M, Grosse S, et al. Surface-plasmon resonances in single metallic nanoparticles. Phys Rev Lett. 1998;80(19):4249–4252.
   Web of Science ®Google Scholar
• Dulkeith E, Niedereichholz T, Klar T, et al. Plasmon emission in photoexcited gold nanoparticles. Phys Rev B. 2004;70(20):205424.
   Web of Science ®Google Scholar
• El-Sayed MA. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res. 2001;34(4):257–264.
   PubMed Web of Science ®Google Scholar
• Loo C, Lowery A, Halas N, et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 2005;5(4):709–711.
   PubMed Web of Science ®Google Scholar
• Gole A, Murphy CJ. Seed-mediated synthesis of gold nanorods: role of the size and nature of the seed. Chem Mater. 2004;16(19):3633–3640.
   Web of Science ®Google Scholar
• Ai SHERMAN, Ter-pogossian M. Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer. 1953;6(6):1238–1240.
   PubMed Web of Science ®Google Scholar
• Rayavarapu RG, Petersen W, Hartsuiker L, et al. In vitro toxicity studies of polymer-coated gold nanorods. Nanotechnology. 2010;21(14):145101.
   PubMed Web of Science ®Google Scholar
• Kabashin A. Plasmonics nanorod metamaterials for biosensing. Nat Mater. 2009;8(11):867–871.
   PubMed Web of Science ®Google Scholar
• Gobin AM, Lee MH, Halas NJ, et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 2007;7(7):1929–1934.
   PubMed Web of Science ®Google Scholar
• Hilgenbrink AR, Low PS. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci. 2005;94(10):2135–2146.
   PubMed Web of Science ®Google Scholar
• Tong L, Wei Q, Wei A, et al. Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. Photochem Photobiol. Internet]. 2009 [cited 2019 Jun 26];85:21–32. Available from ;(1):. http://www.ncbi.nlm.nih.gov/pubmed/19161395.
   PubMed Web of Science ®Google Scholar
• Huff TB, Hansen MN, Zhao Y, et al. Controlling the cellular uptake of gold nanorods. Langmuir. 2007;23(4):1596–1599.
   PubMed Web of Science ®Google Scholar
• Chen Y, Bian X, Aliru M, et al. Hypoxia-targeted gold nanorods for cancer photothermal therapy. Oncotarget. 2018;9(41):26556.
   PubMedGoogle Scholar
• Ren QQ, Bai LY, Zhang XS, et al. Preparation, modification, and application of hollow gold nanospheres. J Nanomater. 2015;6:1–7.
   Google Scholar
• Setua S, Ouberai M, Piccirillo SG, et al. Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma. Nanoscale. 2014;6(18):10865–10873.
   PubMed Web of Science ®Google Scholar
• Farjami Shayesteh S, Saie M. The effect of surface plasmon resonance on optical response in dielectric (core)-metal (shell) nanoparticles. Indian Acad Sci. 2015;85:1245–1255.
   Google Scholar
• Hirsch L. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci. 2003;100(23):13549–13554.
   PubMed Web of Science ®Google Scholar
• Loo C, Lowery A, Halas N, et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 2005;5(4):709–711.
   PubMed Web of Science ®Google Scholar
• Shanbah PP, Iyer V, Shetty T. Gold nanoshells: a ray of hope in cancer diagnosis and treatment. Nucl Med Biomed Imaging 2. 2017;2:1–5.
   Google Scholar
• Wang Y. Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain. Nano Lett. 2004;4(9):1689–1692.
   Web of Science ®Google Scholar
• Stern JM, Stanfield J, Lotan Y, et al. Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. J Endourol. 2007;21(8):939–943.
   PubMed Web of Science ®Google Scholar
• Cobley CM, Au L, Chen J, et al. Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery. Expert Opin Drug Deliv. 2010;7(5):577–587.
   PubMed Web of Science ®Google Scholar
• Ngwa W, Kumar R, Sridhar S, et al. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine. 2014;9(7):1063–1082.
   PubMed Web of Science ®Google Scholar
• Paciotti GF, Myer L, Weinreich D, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv J Deliv Target Ther Agents. 2004;11:169–183.
   Google Scholar
• S Jain DHJO. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 2012;85(1010):101–113.
   PubMed Web of Science ®Google Scholar
• Dreaden EC, Alkilany AM, Huang X, et al. The golden age: gold nanoparticles for biomedicine. Chem Soc Rev. 2012;41:2740–2779.
   PubMed Web of Science ®Google Scholar
• Joyce C, Fothergill SM, Xie F. Recent advances in gold-based metal enhanced fluorescence platforms for diagnosis and imaging in the near-infrared. Mater. Today Adv.. 2020;7: 100073.
   Google Scholar
• Sylvestre JP, Poulin S, Kabashin AV, et al. Surface chemistry of gold nanoparticles produced by laser ablation in aqueous media. J Phys Chem B. 2004;108:16864–16869.
   Web of Science ®Google Scholar
• Alkilany AM, Nagaria PK, Hexel CR, et al. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small. 2009;5(6):701–708.
   PubMed Web of Science ®Google Scholar
• Connor EE, Mwamuka J, Gole A, et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1(3):325–327.
   PubMed Web of Science ®Google Scholar
• Haume K. Gold nanoparticles for cancer radiotherapy: a review, cancer. Nano. 2016;7:8.
   Google Scholar
• Schwartzberg AM, Olson TY, Talley CE, et al. Synthesis, characterization, and tunable optical properties of hollow gold nanospheres †. J Phys Chem B. 2006;110(40):19935–19944.
   PubMed Web of Science ®Google Scholar
• Tsai C-Y, Lu S-P, Lin J-W, et al. High sensitivity plasmonic index sensor using slablike gold nanoring arrays. Appl Phys Lett. 2011;98(15):153108.
   PubMed Web of Science ®Google Scholar
• Mahmoud MA, Garlyyev B, El-Sayed MA. Determining the mechanism of solution metallic nanocatalysis with solid and hollow nanoparticles: homogeneous or heterogeneous. J Phys Chem C. 2013;117(42):21886–21893.
   Web of Science ®Google Scholar
• Melancon MP, Lu W, Yang Z, et al. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther. 2008;7(6):1730–1739.
   PubMed Web of Science ®Google Scholar
• Lu W, Huang Q, Ku G, et al. Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials. 2010;31(9):2617–2626.
   PubMed Web of Science ®Google Scholar
• Tong L, Cobley CM, Chen J, et al. Bright three-photon luminescence from gold/silver alloyed nanostructures for bioimaging with negligible photothermal toxicity. Angew Chem Int Educ. 2010;49(20):3485–3488.
   PubMed Web of Science ®Google Scholar
• Schwartzberg AM, Olson TY, Talley CE, et al. Synthesis, characterization, and tunable optical properties of hollow gold nanospheres†. J Phys Chem B. 2006;110(40):19935–19944.
   PubMed Web of Science ®Google Scholar
• Jenkins SV, Gohman TD, Miller EK, et al. Synthesis of hollow gold-silver alloyed nanoparticles: a “Galvanic Replacement” experiment for chemistry and engineering students. J Chem Educ. 2015;92(6):1056–1060.
   Web of Science ®Google Scholar
• Preciado-Flores S, Wang D, Wheeler DA, et al. Highly reproducible synthesis of hollow gold nanospheres with near infrared surface plasmon absorption using PVP as stabilizing agent. J Mater Chem. 2011;21(7):2344–2350.
   Web of Science ®Google Scholar
• Hu T, Lin Y, Yan J, et al. Synthesis of hollow gold nanoparticles on the surface of indium tin oxide glass and their application for plasmonic biosensor. Spectrochim Acta - Part A Mol Biomol Spectrosc. 2013;110:72–77.
   PubMed Web of Science ®Google Scholar
• Liang HP, Wan LJ, Bai CL, et al. Gold hollow nanospheres: tunable surface plasmon resonance controlled by interior-cavity sizes. J Phys Chem B. 2005;109(16):7795–7800.
   PubMed Web of Science ®Google Scholar
• Lu W, Xiong C, Zhang G, et al. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res. 2009;15(3):876–886.
   PubMed Web of Science ®Google Scholar
• You J, Zhang R, Zhang G, et al. Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release. J Control Release. 2012;158(2):319–328.
   PubMed Web of Science ®Google Scholar
• You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano. 2010;4(2):1033–1041.
   PubMed Web of Science ®Google Scholar
• Imanparast A, Bakhshizadeh M, Salek R, et al. Pegylated hollow gold-mitoxantrone nanoparticles combining photodynamic therapy and chemotherapy of cancer cells. Photodiagnosis Photodyn Ther. 2018;23:295–305.
   PubMed Web of Science ®Google Scholar
• Abdollahi SN, Naderi M, Amoabediny G. Synthesis and characterization of hollow gold nanoparticles using silica spheres as templates. Colloids Surf A Physicochem Eng Asp. 2013;436: 1069–1075.
   Web of Science ®Google Scholar
• Kohler N, Sun C, Wang J, et al. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir. 2005;21(19):8858–8864.
   PubMed Web of Science ®Google Scholar
• Adams S, Thai D, Mascona X, et al. Key factors affecting the reproducibility of synthesis and growth mechanism of near-infrared absorbing hollow gold nanospheres. Chem Mater. 2014;26(23):6805–6810.
   Web of Science ®Google Scholar
• Guo M, He J, Li Y, et al. One-step synthesis of hollow porous gold nanoparticles with tunable particle size for the reduction of 4-nitrophenol. J Hazard Mater. 2016;310:89–97.
   PubMed Web of Science ®Google Scholar
• Olson TY, Schwartzberg AM, Orme CA, et al. Hollow gold-silver double-shell nanospheres: structure, optical absorption, and surface-enhanced Raman scattering. J Phys Chem C. 2008;112(16):6319–6329.
   Web of Science ®Google Scholar
• Baygazieva EK, Yesmurzayeva NN, Tatykhanova GS, et al. Polymer protected gold nanoparticles: synthesis, characterization and application in catalysis. Int J Biol Chem. 2014;7(1):14–23.
   Google Scholar
• Zhang X-F, Liu Z-G, Shen W, et al. Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci. 2016;17(9):1534.
   PubMed Web of Science ®Google Scholar
• Benyettou F, Rezgui R, Ravaux F, et al. Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells. J Mater Chem B. 2015;3(36):7237–7245.
   PubMed Web of Science ®Google Scholar
• Chen H, Liu Y, Zhao G. Synthesis and characterization of hollow silver spheres at room temperature. Electron Mater Lett. 2011;7(2):151–154.
   Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update. Bioeng Transl Med. 2019;4(3):1–16.
   Web of Science ®Google Scholar
• Mullard A. FDA approves landmark RNAi drug. Nat Rev Drug Discov. 2018;17:613.
   Web of Science ®Google Scholar
• Mullard A. FDA approves landmark tissue-agnostic cancer drug. Nat Rev Drug Discov. 2018;18:7.
   Web of Science ®Google Scholar
• Doxil® BY. - The first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117–134.
   PubMed Web of Science ®Google Scholar
• Saving Patients’ Lives Medical B.V. Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients. 2020; Feb 10, 2020- Nov 9, 2020. Identifier-NCT04261777.
   Google Scholar
• National Cancer Institute. NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery. Clin. U.S. Natl. Libr. Med. 2017; Jan 13, 2017- Oct 27, 2020. Identifier- NCT03020017.
   Google Scholar
• A Study to Evaluate the Safety. Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM). 2016; May 10, 2016- Aug 29, 2019. Identifier- NCT02766699.
   Google Scholar
• National Library of Medicine (US). Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck. 2017; July 18, 2016- Feb 9, 2017. Identifier- NCT00848042.
   Google Scholar
• Donaldson L. ‘Cornell Dots’ receive approval for clinical trials. Mater Today. 2011;14(4):131.
   Web of Science ®Google Scholar
• Gustave Roussy Grand Paris|National Cancer Institute, France CC. AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy. 2019; May 17, 2018-May-21. Identifier- NCT03308604.
   Google Scholar
• Verry C, Sancey L, Dufort S, et al. Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol. BMJ Open. 2019; (2):9.e023591. DOI:10.1136/bmjopen-2018-023591.
   PubMed Web of Science ®Google Scholar
• US National Library of Medicine. History of Changes for Study: NCT01713764. 2013; 6–8.
   Google Scholar
• GE Healthcare. Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination. 2018; Mar 6, 2018- Dec 4, 2019. Identifier- NCT03455283.
   Google Scholar
• Bonvalot S, Rutkowski PL, Thariat J, et al. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial. Lancet Oncol. 2019;20(8):1148–1159.
   PubMed Web of Science ®Google Scholar